{"id":619948,"date":"2022-10-06T17:52:01","date_gmt":"2022-10-06T17:52:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=619948"},"modified":"2022-10-06T17:52:01","modified_gmt":"2022-10-06T17:52:01","slug":"cushings-syndrome-market-to-register-sustainable-growth-during-the-forecast-period-202232-strongbridge-biopharma-crinetics-cyclacel-sparrow-pharma-astrazeneca-corcept-therapeutics","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/cushings-syndrome-market-to-register-sustainable-growth-during-the-forecast-period-202232-strongbridge-biopharma-crinetics-cyclacel-sparrow-pharma-astrazeneca-corcept-therapeutics_619948.html","title":{"rendered":"Cushing’s Syndrome Market to Register Sustainable Growth During the Forecast Period (2022-32) | Strongbridge Biopharma, Crinetics, Cyclacel, Sparrow Pharma, AstraZeneca, Corcept Therapeutics"},"content":{"rendered":"
\n
\"Cushing's<\/a><\/div>\n
\n
Delveinsight Business Research LLP<\/div>\n<\/div>\n<\/div>\n
As per DelveInsight, the Cushing\u2019s Syndrome Market is expected to grow in the coming years owing to the rise in the prevalent population of Cushing\u2019s Syndrome in the 7MM. Additionally, the extensive research and development activities of pharmaceutical companies in the therapeutics segment and the expected launch of therapies will also fuel market growth.<\/div>\n

DelveInsight’s “Cushing’s Syndrome Market Insights, Epidemiology, and Market Forecast 2032<\/strong>” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Cushing’s Syndrome Market size, share, and trends in the seven major market (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).<\/p>\n

The Cushing’s Syndrome market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice\/algorithm, key drivers & barriers impacting the market growth, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. <\/p>\n

\"Cushing's<\/strong><\/p>\n

Cushing’s Syndrome: An Overview<\/strong><\/p>\n

Cushing’s Syndrome (CS) is a disorder that occurs when the body makes too much of the hormone cortisol over a long period of time. Cortisol is sometimes called the “stress hormone” because it helps the body respond to stress.<\/p>\n

The most common cause of CS is the long-term, high-dose use of cortisol-like glucocorticoids. These medicines are used to treat other medical conditions, such as asthma, rheumatoid arthritis, and lupus. Other people develop endogenous Cushing’s syndrome because their bodies make too much cortisol. Several types of tumors can cause the body to make excess cortisol, such as Pituitary tumors, Ectopic ACTH-producing tumors, and Adrenal tumors.<\/p>\n

Treatment of Cushing’s Syndrome depends on the underlying cause of excess cortisol but may perhaps include surgery, radiation, chemotherapy, or the use of cortisol-inhibiting drugs.<\/strong><\/em><\/p>\n

Cushing’s Syndrome Market Key Facts<\/strong><\/p>\n